Literature DB >> 6814471

Ventilatory and cardiovascular effects of BHT 933 in volunteers.

B J Pleuvry, J B Redpath.   

Abstract

In 12 healthy volunteers BHT 933 in doses of 5 and 10 mg had minimal effects on ventilation, a small fall in total volume occurred with the highest dose. BHT 933 (5 mg) reduced both systolic and diastolic blood pressure, but had little effect on autonomic reactivity tests, whereas the 10 mg dose reduced the response to these tests. Both doses of BHT 933 caused marked sedation. It is concluded that 5 mg BHT 933 orally presents the most suitable profile of activity for further studies into its usefulness as an anti-tussive and antihypertensive.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814471      PMCID: PMC1427591          DOI: 10.1111/j.1365-2125.1982.tb02029.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8,-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type".

Authors:  W Kobinger; L Pichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

2.  Effects of placebo and BHT 933 on autonomic reactivity.

Authors:  J B Redpath; B J Pleuvry
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

3.  Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.

Authors:  D P Clough; R Hatton
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

4.  Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the alpha 2-type by B-HT 933.

Authors:  P B Timmermans; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1980-05-02       Impact factor: 4.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.